Cardiovascular disease is the leading cause of death in the industrialized world. Being multiple risk factors for atherosclerosis it emerged the concept of global cardiovascular risk assessment. Furthermore, risk factors clustered together. The metabolic syndrome, as the confluence of risk factors of metabolic origin, is associated with cardiovascular disease and type 2 diabetes. A clinical diagnosis of metabolic syndrome allows to identify individuals at high risk of developing cardiovascular disease and type 2 diabetes and it affects therapeutic strategies for primary prevention. Although changes in lifestyle are fundamental to treat all the risk factors, pharmacologic interventions targeting the single component of the syndrome also play an important role. Increasingly, an alternative strategy is available and attractive: the introduction of therapies targeting multiple risk factors simultaneously through a combination of 2 or more drugs into a single capsule.

[Cardiovascular disease and metabolic syndrome] / Maranghi, Marianna; P., Coletta; Durante, Cosimo; D., Pergolini; Filetti, Sebastiano. - In: RECENTI PROGRESSI IN MEDICINA. - ISSN 0034-1193. - 97:12(2006), pp. 719-726.

[Cardiovascular disease and metabolic syndrome].

MARANGHI, MARIANNA;DURANTE, COSIMO;FILETTI, SEBASTIANO
2006

Abstract

Cardiovascular disease is the leading cause of death in the industrialized world. Being multiple risk factors for atherosclerosis it emerged the concept of global cardiovascular risk assessment. Furthermore, risk factors clustered together. The metabolic syndrome, as the confluence of risk factors of metabolic origin, is associated with cardiovascular disease and type 2 diabetes. A clinical diagnosis of metabolic syndrome allows to identify individuals at high risk of developing cardiovascular disease and type 2 diabetes and it affects therapeutic strategies for primary prevention. Although changes in lifestyle are fundamental to treat all the risk factors, pharmacologic interventions targeting the single component of the syndrome also play an important role. Increasingly, an alternative strategy is available and attractive: the introduction of therapies targeting multiple risk factors simultaneously through a combination of 2 or more drugs into a single capsule.
2006
01 Pubblicazione su rivista::01a Articolo in rivista
[Cardiovascular disease and metabolic syndrome] / Maranghi, Marianna; P., Coletta; Durante, Cosimo; D., Pergolini; Filetti, Sebastiano. - In: RECENTI PROGRESSI IN MEDICINA. - ISSN 0034-1193. - 97:12(2006), pp. 719-726.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/238516
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 64
social impact